Celularity Receives Nasdaq Notice Regarding Form 10-Q
August 22, 2025 17:30 ET | Source: Celularity, Inc. FLORHAM PARK, N.J.,…
Ansell Receives Frost & Sullivan’s 2025 Global Sustainable Hospital Supplies Company of the Year Award
Ansell is recognised for its leadership in hospital supply sustainability, visionary innovation,…
Cisco Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition for Leadership in Mobile IoT Platforms
Acknowledged for driving continuous innovation and delivering flexible, scalable solutions that enable…
Youxin Technology Ltd Receives Nasdaq Notifications Regarding Minimum Bid and Market Value of Listed Securities Requirements
Guangzhou, China, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Youxin Technology Ltd (Nasdaq:…
Sangfor Receives Frost & Sullivan’s 2025 APAC Company of the Year Recognition for Excellence in SASE
Sangfor's customer-first innovation and unified SASE architecture deliver real-world impact across APAC.…
CTERA Receives Frost & Sullivan’s 2025 Global Company of the Year Award for Excellence in Hybrid Cloud Storage Leadership
Recognized for innovation and exceptional customer impact in the hybrid cloud storage…
Bracco Imaging Receives Regulatory Approval in China for SonoVue in the Assessment of Fallopian Tube Patency
New indication of SonoVue® supports non-invasive assessment of female infertility through contrast-enhanced…
Ericsson Receives Frost & Sullivan’s 2025 Global SASE for the Distributed Enterprise Enabling Technology Leadership Recognition for Excellence in Cellular-Optimized Secure Networking
Recognized for driving digital innovation and customer success through unmatched application diversity,…
Purespring Therapeutics receives UK CTA approval for Phase I/II clinical trial of PS-002 in patients with primary IgA nephropathy (IgAN)
First patient in Phase I/II clinical trial expected to be enrolled in…
Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer
TAIPEI, Aug. 4, 2025 /PRNewswire/ -- Anbogen Therapeutics today announced that the…
